The FDA approves a new non-opioid pain pill, Journavx, to treat acute pain in adults. It's a first-generation non-addictive ...

Still, there’s another piece of evidence that his futuristic pot pills could be working: People keep buying them. Level has recently expanded to distributing its pills in a seventh state. He could be ...

Only around one in every 10 treatments were found to be effective in relieving lower back pain, according to a new study ...

Emmanuel Valentin, 40, of Miami, pleaded guilty to tampering with consumer products on Dec. 13, 2024, according to a press ...

Could aspirin keep cancer from spreading? A new study from the University of Cambridge suggests that the common pain ...

We increasingly hear pleas from those who are suffering agonizing pain not only about pain management but also about ways to end their lives.

Latigo Biotherapeutics has whipped together a $150 million series B fundraising round to advance a pipeline of non-opioid ...

Low back pain affects an estimated one in four American adults and is the leading contributor to disability globally. In most ...

A new study may help to explain why there is an over-representation of women experiencing chronic pain compared to men and why pain medication may not be as effective for women as it is for men.

A new study led by University of Calgary researchers may help to explain why there is an over-representation of women ...